TrialJAMA oncology2025

Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial.

Nikita Sushentsev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.